Ocular Therapeutix OCUL Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $10.79M+0.8% | $13.25M-22.4% | $14.54M-5.7% | $13.46M-18.1% | $10.7M-27.6% | ||
| $1.33M+5.3% | $1.59M+29.6% | $1.77M+13.6% | $1.94M+28.8% | $1.26M-4.8% | ||
| $9.46M+0.2% | $11.66M-26.5% | $12.77M-7.9% | $11.52M-22.9% | $9.44M-29.8% | ||
| 87.7%-0.5pp | 88%-4.8pp | 87.8%-2.1pp | 85.6%-5.3pp | 88.2%-2.8pp | ||
| $66.21M+54.5% | $50.8M+23.9% | $52.36M+41.3% | $51.08M+77.0% | $42.86M+107% | ||
| $16.58M+17.2% | $12.96M+19.5% | $13.09M+23.8% | $13.73M+37.4% | $14.15M+38.9% | ||
| $20.01M+22.4% | $17.66M+21.0% | $16.02M+31.0% | $14.35M-27.1% | $16.35M+15.6% | ||
| $104.13M+39.5% | $83.01M+22.7% | $83.24M+35.5% | $81.1M+35.1% | $74.62M+60.8% | ||
| -$93.34M-46.0% | -$69.76M-37.9% | -$68.7M-49.3% | -$67.64M-55.2% | -$63.92M-102% | ||
| -865.5%-268pp | -526.5%-230pp | -472.3%-174pp | -502.6%-237pp | -597.5%-383pp | ||
| $2.78M-6.9% | $2.83M-8.8% | $3M-6.9% | $3.02M-5.6% | $2.98M-26.3% | ||
| $4.73M+3,576% | $5.11M— | -$720K-108% | -$173K+7.5% | -$136K+99.6% | ||
| -$88.61M-38.3% | -$64.65M-33.6% | -$69.42M-90.2% | -$67.81M-54.9% | -$64.05M+1.2% | ||
| -821.6%-223pp | -488%-205pp | -477.3%-241pp | -503.9%-238pp | -598.7%-160pp | ||
| -$0.40-5.3% | -$0.27+3.6% | -$0.38-72.7% | -$0.39-50.0% | -$0.38+22.4% | ||
| -$92.06M-46.3% | -$68.51M-38.1% | -$67.63M-50.2% | -$66.62M-56.2% | -$62.94M-105% | ||
| -853.6%-265pp | -517.1%-227pp | -465%-173pp | -494.9%-236pp | -588.3%-381pp | ||
| -$93.34M-46.0% | -$69.76M-37.9% | -$68.7M-49.3% | -$67.64M-55.2% | -$63.92M-102% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ocular Therapeutix's revenue?
- Ocular Therapeutix (OCUL) generated $52.0M in revenue over the trailing twelve months, down 12.8% year over year.
- Is Ocular Therapeutix profitable?
- Ocular Therapeutix is not currently profitable: it reported a net loss of $290.5M over the trailing twelve months, a -558.2% net margin.
- What are Ocular Therapeutix's profit margins?
- Gross margin is 87.2% and operating margin is -575.4%, with a -558.2% net margin.
- What is Ocular Therapeutix's earnings per share?
- Ocular Therapeutix's diluted EPS over the trailing twelve months is $-1.44.
- Where does Ocular Therapeutix's income statement data come from?
- Every line is extracted from Ocular Therapeutix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
